Erratum: Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion (Clinical Cancer Research (2011) 17 (1297–1305) DOI: 10.1158/1078-0432.CCR-10-0993);Regulation of HMGA1 expression by MicroRNA-296 affects prostate cancer growth and invasion

Clinical Cancer Research

Volumn 17, Issue 6, 2011, Pages 1297-1305

  Wei, Jian Jun ^a   Wu, Xinyu ^b   Peng, Yi ^b   Shi, Guizhi ^b   Olca, Basturk ^b   Yang, Ximing ^a   Daniels, Garrett ^b   Osman, Iman ^b,c   Ouyang, Jiangyong ^b   Hernando, Eva ^b   Pellicer, Angel ^b   Rhim, Johng S ^d   Melamed, Jonathan ^b   Lee, Peng ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; MICRORNA; MICRORNA 296; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; HMGA1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TRANSLATION REGULATION;

EID: 79952721604     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-20-0229     Document Type: Erratum

References (28)

1. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996;13:2439-46. (Pubitemid 27026027)
2. Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem 1988;263:18338-42. (Pubitemid 19005110)
3. Tamimi Y, Van Der Poel HG, Denyn MM, Umbas R, Karthaus HF, Debruyne FM, et al. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 1993;53:5512-6. (Pubitemid 23342176)
4. Tamimi Y, Van Der Poel HG, Karthaus HF, Debruyne FM, Schalken JA. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. Br J Cancer 1996;74:573-8. (Pubitemid 26279052)
5. Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ. Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene 1999;18:5076-87. (Pubitemid 29443753)
6. Pierantoni GM, Rinaldo C, Mottolese M, Di Benedetto A, Esposito F, Soddu S, et al. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 2007;117:693-702. (Pubitemid 46348527)
7. Diana F, Di Bernardo J, Sgarra R, Tessari MA, Rustighi A, Fusco A, et al. Differential HMGA expression and post-translational modifications in prostatic tumor cells. Int J Oncol 2005;26:515-20.
8. Takaha N, Hawkins AL, Griffin CA, Isaacs WB, Coffey DS. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res 2002;62:647-51. (Pubitemid 34126934)
9. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61. (Pubitemid 43271657)
10. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008;27:1788-93. (Pubitemid 351380263)
11. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007;67:6130-5. (Pubitemid 47037493)
12. Lin SL, Chiang A, Chang D, Ying SY. Loss of mir-146a function in hormone-refractory prostate cancer. RNA 2008;14:417-24. (Pubitemid 351397806)
13. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgenregulated miRNA suppresses Bak1 expression and induces androgen- independent growth of prostate cancer cells. Proc Natl Acad Sci U S A 2007;104:19983-8.
14. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007;6:2585-90. (Pubitemid 350224037)
15. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007;21:1025-30. (Pubitemid 46686471)
16. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576-9. (Pubitemid 46449474)
17. Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P, et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 2007;46:336-47. (Pubitemid 46411325)
18. Wang LG, Ossowski L, Ferrari AC. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene 2004;23:5175-84. (Pubitemid 38980350)
19. Gu Y, Li H, Miki J, Kim KH, Furusato B, Sesterhenn IA, et al. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Exp Cell Res 2006;312:831-43.
20. Kloosterman WP, Wienholds E, Ketting RF, Plasterk RH. Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res 2004;32:6284-91. (Pubitemid 40202087)
21. Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers MP, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006;126:503-14. (Pubitemid 44163608)
22. Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, et al. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res 2009;69:3332-8.
23. Jiang X, Wang Y. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells. Biochemistry 2006;45:7194-201. (Pubitemid 43877408)
24. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006;25:6202-10. (Pubitemid 44527851)
25. Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P, et al. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res 2008;6:663-73. (Pubitemid 351521848)
26. Hauke S, Leopold S, Schlueter C, Flohr AM, Murua Escobar H, Rogalla P, et al. Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. Biochim Biophys Acta 2005;1729:24-31. (Pubitemid 40732421)
27. Zhang Q, Zhang K, Zou Y, Perna A, Wang Y. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins. J Am Soc Mass Spectrom 2007;18:1569-78. (Pubitemid 47302319)
28. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6. (Pubitemid 38697282)